NCT03313713

Beta-glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT)

Randomised Placebo-Controlled Clinical Trial to Assess the Medium-term Effect of 3 g/Day of a Beta-glucan on Lipid Profile, Glycemia and Intestinal Health, in Moderately Hypercholesterolemic Subjects

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 85 (estimated)
• Sponsor: University of Bologna · Academic / Other
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This will be a randomized, placebo-controlled, clinical trial carried out on moderately hypercholesterolemic subjects who will consume 3 g per day of beta-glucans, in order to evaluate the effects on lipid profile, glycemia and intestinal function

Detailed description

In order to assess the mid term effects of beta-glucans on lipid profile, glycemia and intestinal function, moderately hypercholesterolemic subjects will be involved in a cross-over study and supplemented for 8 weeks with 3 g/day of beta-glucans or placebo. The two intervention periods will be spaced by a 4 week washout period

Conditions

• Atherosclerosis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Beta-glucans	Placebo consumption at breakfast (3 g per day)
DIETARY_SUPPLEMENT	Placebo	Placebo consumption at breakfast (3 g per day)

Timeline

• Start date: 2017-04-26
• Primary completion: 2017-12-01
• Completion: 2018-03-01
• First posted: 2017-10-18
• Last updated: 2017-10-19

Locations

1 site across 1 country: Italy